Objectives: Prolonged nucleoside reverse transcriptase inhibitors (NRTI) exposure can lead to microvesicular steatosis. We hypothesized that thymidine analogues might interfere with autophagy in hepatocytes, a lysosomal degradation pathway implicated in cell survival and regulation of hepatocyte lipid metabolism.
Introduction
Prolonged exposure to nucleoside reverse transcriptase inhibitors (NRTI), particularly thymidine analogues, has been associated with microvesicular steatosis, development of lactic acidosis [4] [5] [6] [7] [8] . In-vitro experiments demonstrated that the thymidine analogues zidovudine (ZDV) and stavudine (d4T), but not the cytidine analogue lamivudine (3TC), inhibit HepG2 cell growth and induce intracellular lipid accumulation [8] . Excessive presence of lipid droplets in the cytoplasm of parenchymal cells represents a situation of fatty liver or steatosis [9] . However, the fact that both d4T and ZDV disturb hepatocyte function in a similar way, but only d4T was found to deplete mtDNA, was suggestive for additional mechanisms [8] .
In-vitro experiments with nonhepatocyte models demonstrated that NRTI induce accumulation of dysfunctional mitochondria, increased reactive oxygen species (ROS) production, enhanced apoptosis and growth arrest [10] . Interestingly, similar effects have been associated with autophagy inhibition per se [11] [12] [13] .
The cellular degradation pathway of autophagy was recently implicated in the regulation of hepatocyte lipid metabolism [14] . Specifically, defective autophagy has been associated with increased lipid droplet contents in murine hepatocytes both in vitro and in vivo [14] . Based on these results, compromised autophagic homeostasis has been proposed to play a role in the pathogenesis of diseases with lipid dysregulation such as metabolic syndrome [14] . Interestingly, interference with autophagic homeostasis has been recently implicated in the pathogenic mechanism of non-NRTI efavirenz-associated hepatotoxicity [15] .
Despite substantial progress in our understanding of how NRTI might damage mitochondria [16, 17] , little is known about their effect on the elimination of dysfunctional mitochondria. Autophagic removal of dysfunctional mitochondria, however, relates to the depletion of proapoptotic signals and represents an integral part of the maintenance of cellular survival and homeostasis [18] .
We hypothesized that in addition to the well studied mitochondrial toxicity of thymidine analogues, these drugs have the ability to suppress hepatocyte autophagy. We expected that this would cause impaired clearance of dysfunctional mitochondria, increased ROS production and intracellular lipid accumulation, increased apoptosis and reduced hepatocyte proliferation. We speculated that these effects could help to explain the development of nonalcoholic hepatic steatosis in HIV patients.
Materials and methods
Cell culture HepG2 cells were from American Type Culture Collection (ATCC). HUH7 cell line was kindly provided by Dr Heiner Wedemeyer (MHH, Germany). Both cell lines were maintained in ATCC-formulated Eagle's Minimum Essential Medium containing 10% fetal calf serum (FCS) with 100U/100 mg/ml penicillin/streptomycin and cultured as previously described [8] .
Zidovudine, d4T and 3TC (Sigma-Aldrich, St. Louis, Missouri, USA) were dissolved in dimethyl sulfoxide (DMSO) . Drug concentrations were around the therapeutic C max levels ZDV (6 mmol/l), d4T (3 mmol/l) and 3TC (8 mmol/l) as discussed in [8, 19] . In experiments addressing dose dependency, higher concentration (5 Â and 30 Â C max ) were used. Established modulators of autophagy were used at concentration previously reported in similar in-vitro experiments 3-methyladenine (3-MA) (3-10 mmol/l) [20] , wortmannin (30-100 nmol/l) [20] , LY294002 (7-20 mmol/l) [20] , nocodazole (12-50 mmol/l) [21] , vinblastine (12-50 mmol/l) [22] , rapamycin (5 mmol/l) [20] , PP242 (5 mmol/l), ammonium chloride (ACH) (10-20 mmol/l) [14] , hydrohychloroquine (HCQ) and chloroquine (CQ) (5-10 mmol/l) [23] . ACH, 3-MA, CQ and HCQ were dissolved in PBS, all the other reagents were dissolved in DMSO. The highest concentration of the solvent used in the incubation experiments (DMSO 0.1%) did not affect cellular viability. Hanks' Balanced Salt Solution containing 6 mmol/l glucose (starvation medium) was used in experiment with starvation-induced autophagy.
Primary human hepatocyte isolation and culturing was performed using a modified two-step collagenase perfusion technique as previously reported [24] and explained in the supporting online material, http:// links.lww.com/QAD/A246. Isolation of human hepatic cells was approved by the Hannover Medical School ethics committee and patients informed consent.
Constructs and retroviral infection pBABEpuro green fluorescent protein (GFP)-LC3 (plasmid 22405) and pBABE-puro mCherry-EGFP-LC3B (plasmid 22418) generated by Debnath and colleagues [25] were purchased from Addgene. mCherry-EGFP-LC3B and GFP-LC3 sequences were inserted into retroviral constructs used for cell transduction. Retroviral production and cell transduction were essentially performed as previously described [26] . Transduced cells were subjected to puromycin selection (1 mg/ml; Sigma, Taufkirchen, Germany) for 3 days and GFP, GFP/mCherry-positive cells were fluorescenceactivated cell sorting (FACS) sorted (FACSAria). The formation of experimental artefacts as a result of potential bulky GFP-LC3 or mCherry-GFP-LC3 aggregates was ruled out by the use of stably transduced cells and appropriate clone selection [27, 28] . applied as controls according to the instructions of the manufacturer (sc-108080, sc-108084, Santa Cruz Biotechnology). Lentiviral particles with up to five distinct expression constructs were utilized for transduction. Transduction efficiency at the end of puromycin selection exceeded 96% as determined by the number of GFPpositive cells.
Analysis of nucleoside reverse transcriptase inhibitor effects on cellular autophagic activity Autophagosomes correspond to an intermediate structure of a dynamic process and their total amount at a particular point of time is a function of their generation and disappearance after autophagosome-lysosome fusion [27, 28] . An increase in autophagosome number may signify either induction of autophagy or inhibition of autophagosome maturation (autophagosome-lysosome fusion). Measurement of autophagic flux allows discrimination between these two situations [27, 28] .
GFP-LC3-I to GFP-LC3-II conversion was detected by western blotting using anti-LC-3B antibody (Sigma-Aldrich) [28] . The amount of LC3-II has been found to correlate with the amount of autophagic membrane [28] [29] [30] . Furthermore, we measured autophagic flux using antibody against the specific substrate p62 (BD Transduction Laboratories, Beckton Dickinson and Co., Franklin Lakes, New Jersey, USA). Total cellular p62 amount has been shown to negatively correlate with autophagic activity [28] . Western blotting was performed as described previously [31, 32] . Densitometry of p62 and LC3-II bands was performed using LabImage 1D Software (Kapelan Bio-Imaging Solutions, Germany) and normalized to the optical density of actin [27] .
GFP-LC3 and mCherry-GFP-LC3 were visualized by conventional fluorescence microscopy according to recently updated recommendation [28] . GFP-LC3 or mCherry-GFP-LC3 cytoplasmic pool is detected as a homogeneously dispersed signal and GFP-LC3-II or mCherry-GFP-LC3-II labelled autophagosomes as punctae formation [28] . In each treatment condition fluorescence images were taken from numerous cells from several randomly chosen fields with fluorescein isothiocyanate or Cy3 filter using Olympus IX81 instrument and analySIS (Soft Imaging System GmbH). Quantitative analysis of punctae formation was performed by counting the number of punctae per cell from 20 images containing on average 20 cells per image for each condition. Electron microscopy was performed as explained in the supporting online material, http://links.lww.com/QAD/A246. The process of autophagy involves transient formation of double membrane organelles, which mature into singlemembrane structures (i.e., amphisomes and autolysosomes). Electron microscopy allows visualization of autophagic compartments as organelles that envelope cellular content (i.e., autophagosomes, amphisomes and autolysosomes) [27, 28] .
We took advantage of recently developed flow cytometric assay in order to complement for some of the limitations of autophagic measurement using western blotting and fluorescent microscopy. The method measures autophagic flux by flow cytometric detection of changes in total cellular GFP-LC3 or mCherry-GFP-LC3 signal as previously described [28, 33] . Briefly under conditions of enhanced autophagic flux, a progressive delivery of GFP-LC3 to autolysosome with subsequent degradation takes place. Therefore, increased or decreased autophagic flux is detected as reduced or enhanced total cellular GFP signal correspondingly [28, 33] . Autophagic activity of HUH7 and HepG2 cells was essentially measured as previously described for CHO and HeLa cells [33] . Analysis was performed using LSR II (Becton Dickinson, Biosciences, San Jose, California, USA) and the data of cell counts plotted as GFP fluorescence intensity.
Intracellular neutral lipids accumulation, mitochondrial mass, reactive oxygen and cell viability
Comprehensive description of the analyses of hepatocyte intracellular neutral lipids abundance, total mitochondrial mass, ROS and cell viability is provided in the supporting online material, http://links.lww.com/QAD/A246.
Statistics
The statistical evaluation for comparisons of more than two groups was performed by ANOVA with Dunnett posthoc analysis. The level of significance was set at P less than 0.05. All data are presented as mean AE SD. All calculations were performed using GraphPadPrism 4 (GraphPad Software, San Diego, California, USA).
Results

Zidovudine and stavudine but not lamivudine inhibit autophagy in HUH7 and HepG2 cells
In order to examine the effect of NRTIs on autophagy in hepatocytes we cultured HUH7 and HepG2 cells in the presence or absence of different concentrations of ZDV (6-150 mmol/l) or d4T (3-75 mmol/l) for 24 h. In addition, the cells were incubated with 3-MA (10 mmol/l) or vinblastine-nocodazole (25 mmol/l). In a separate set of incubations, the activator of autophagy PP242 (5 mmol/l) was added to these conditions for the last 4 h.
Semiquantitative western blot analysis suggested a potential increase in LC3-II by ZDV and d4T ( Fig. 1a ). Such an increase may represent either increased autophagosome formation as a result of enhanced autophagic activity or inhibition of autophagosome maturation [28] . A similar increase in LC3-II was observed by vinblastine and nocodazole-inhibited autophagy (data not shown). Furthermore, ZDV and d4T incubation appeared to counteract PP242-induced degradation of the autophagic substrate p62, suggestive for a drug-mediated inhibition of autophagic flux ( Fig. 1a ). Again, this effect could be observed with the autophagy inhibitors vinblastine and nocodazole (data not shown). p62 binds directly to LC3 and after selective incorporation into autophagosomes and successful autophagosome-lysosome fusion is degraded by autophagy [28] . It has been established that autophagic activity negatively correlates with total cellular p62 levels [28] .
Zidovudine and stavudine act synergistically with PP242 to induce hepatocyte autophagosome accumulation In order to extend our analyses, we cultured HUH7 and HepG2 cells stably expressing the LC3-GFP fusion protein in the presence or absence of therapeutic C max concentrations of ZDV (6 mmol/l) and d4T (3 mmol/l) for 24 h, 3-MA (10 mmol/l) or vinblastine þ nocodazole (25 mmol/l) for 6 h. In a separate set of the abovementioned incubations PP242 (5 mmol/l) was added for the last 4 h ( Fig. 1b ). Fluorescent microscopy analysis demonstrated a homogeneously distributed LC3-GFP pattern in control HUH7 cultures ( Fig. 1b ). PP242 incubation induced considerable autophagic punctae formation, indicating stimulated autophagosome formation [28] . Punctae formation was also observed in ZDV, d4T and vinblastine-nocodazole-treated cultures (Fig. 1b ). PP242-mediated formation of autophagic punctae was completely abolished by coincubation with the inhibitor of autophagosome formation 3-MA ( Fig. 1b) . In contrast, coincubation with the inhibitors of autophagosome maturation vinblastine-nocodazole, as well as with ZDV or d4T, seemed to exert an additive effect on PP242-mediated punctae formation ( Fig. 1b ).
As autophagosomes correspond to an intermediate structure in a dynamic process, their amount is a function of their generation and their disappearance as a result of autophagosome-lysosome fusion. Therefore, the increased presence of hepatocyte autophagosomes as a result of ZDV and d4T incubation suggests either drug-mediated autophagy induction or inhibition of autophagosome maturation [28] .
Zidovudine and stavudine, but not lamivudine inhibit autophagic flux in hepatocytes
In order to measure the autophagic flux, we took advantage of recently developed and highly sensitive method based on flow cytometric monitoring of LC3 turnover [28, 33] . In the course of the autophagic process, LC3-II from the inner autophagosome membrane undergoes degradation in the autolysosome resulting in a gradual decrease in total cellular LC3 abundance. Therefore, in cellular models stably expressing LC3-GFP fusion protein, increase or decrease in autophagic flux are measured correspondingly as reduction or accumulation in total cellular GFP signal [28, 33] .
In order to validate this method for our experimental system, we incubated HUH7 cells stably expressing GFP-LC3 with 3-MA (10 mmol/l), LY294002 (20 mmol/l), ACH (20 mmol/l), CQ or HCQ (10 mmol/l) in the presence or absence of the autophagy activator PP242 (5 mmol/l) for the last 6 h. As predicted [28, 33] , autophagy inhibition at different stages resulted in an accumulation of total cellular LC3-GFP signal, as demonstrated by flow cytometric analysis (Fig. 1c) .
These results indicated that a reduced autophagic flux leads to slow down in LC3-GFP disappearance (Fig. 1c ). PP242-treated cultures presented substantially decreased GFP signals corresponding to enhanced autophagic flux (Fig. 1C) . Similar results were obtained using rapamycin or starvation (data not shown). Coincubation of autophagy inhibitors with PP242 led to substantially reduced activation (Fig. 1c ).
To better distinguish between inhibition of autophagosome maturation and autophagy induction we cultured HUH7 cells stably expressing LC3-GFP fusion protein in the presence or absence of various NRTI concentrations for 48 h. ZDV and d4T substantially decreased the autophagic flux as demonstrated by accumulation of the total cellular LC3-GFP signal (Fig. 1d) . In contrast, autophagic flux was unaffected by 3TC incubation even at the highest concentrations used. The capacity of ZDV and d4T to suppress autophagy was confirmed by their ability to counteract PP242-mediated activation (Fig. 1d ). Similar results were obtained using rapamycin or starvation (data not shown). Importantly, ZDV and d4T effects on autophagy were dose dependent and detectable at therapeutic C max concentrations (Fig. 1d ).
Zidovudine and stavudine induce accumulation of dysfunctional mitochondria and reactive oxygen species production in hepatocytes Generation of dysfunctional mitochondria and augmented ROS production has been documented as a result of defective autophagy [13] . We, therefore, measured total cellular mitochondria mass and ROS after HUH7 cells were incubated with ZDV (6-150 mmol/l), d4T (3-75 mmol/l) or 3TC (8-200 mmol/l) for up to 6 days. This incubation period was expected to correspond to the minimum time to be necessary for cellular mitochondrial turnover under physiological conditions [34] . ZDV and d4T induced profound hepatocyte mitochondria accumulation at concentration observed in HIV-patient ( Fig. 2a) . In contrast and in line to its lack of effect on autophagy, 3TC left cellular mitochondrial abundance unaffected even at the highest concentration used ( Fig. 2a) . Importantly, ZDV-mediated and d4T-mediated mitochondrial accumulation was accompanied by increased ROS production (Fig. 2b) . These data were in line with the notion that basic autophagy activity is crucial for the elimination of damaged mitochondria and maintenance of the critical mitochondrial homeostasis. Again 3TC had no effect on ROS production (Fig. 2b) .
Collectively, this data suggest that NRTI-mediated inhibition of autophagy hampers the elimination of dysfunctional mitochondria generated in relation to their mitochondrial toxicity.
Zidovudine and stavudine but not lamivudine induce hepatocyte intracellular lipid accumulation
Pharmacological or genetic inhibition of autophagy in hepatocytes can lead to increased lipid droplet triglyceride content in vitro and in vivo [14] . To test this, HUH7 cells were incubated in the presence or absence of different NRTI concentration ZDV (6-150 mmol/l), d4T (3-75 mmol/l) and 3TC (8-200 mmol/l) for up to 6 days. ZDV and d4T induced a substantial hepatocyte intracellular lipid droplet accumulation as compared to untreated control, an effect that was completely absent in 3TC-treated cultures (Fig. 2c ). important component of drug toxicity, we aimed to investigate whether autophagy inhibition per se will interfere with hepatocyte function in our experimental model. We used combinations of autophagy inhibitors acting on autophagosome formation (iAF: LY294002, wortmannin and 3-MA), autophagosome maturation (iAM: vinblastine and nocodazole) and autophagosome acidification (iAA: ammonium chloride, chloroquine and hydroxychloroquine) in order to study the effects of autophagy inhibition on cell growth, viability, dysfunctional mitochondrial accumulation, ROS production and intracellular lipid abundance in HUH7 and HepG2 cell lines. Our results verified that inhibition of the autophagic process at various stages interferes with cellular proliferation (data not shown) and decreases hepatocyte viability (Fig. 3a) . We were also able to associate pharmacologically suppressed autophagy with accumulation of dysfunctional mitochondria (Fig. 3b ) and increased ROS production ( Fig. 3c ). Finally, insufficient autophagy resulted in substantially increased intracellular lipid content (Fig. 3d) . Similar effects were observed using single autophagy inhibitors: 3-MA (10 mmol/l), LY294002 (20 mmol/l), wortmannin (100 nmol/l), vinblastine (24 mmol/l) and nocodazole (24 mmol/l), ACH (20 mmol/l), CQ and HCQ (10 mmol/l) for 72 h (Supplementary Figure 1 , http:// links.lww.com/QAD/A246).
Pharmacological and genetic inhibition of autophagy reiterates the effects of zidovudine and stavudine on hepatocytes
For almost all of the currently available pharmacological inhibitors of autophagy one has to assume that they may have pleotropic effects. Therefore, we aimed to verify the above-mentioned observations using autophagy-specific shRNA-mediated knockdown of ATG5 [28] . Genetic inhibition resulting in almost 60% decrease in ATG5 mRNA expression ( Fig. 3f ) confirmed reduced cell viability (Fig. 3e ), mitochondrial mass accumulation (Fig. 3g ), increased ROS formation ( Fig. 3h ) and intracellular lipid accumulation (Fig. 3i) in HepG2 cells and HUH7 cells (data not shown).
Taken together these results suggest that both a semispecific pharmacologic as well as a highly specific genetic inhibition of autophagy in hepatocytes result in accumulation of damaged mitochondria, ROS formation, compromised viability and accumulation of intracellular lipids recapitulating the effects of ZDV and d4T.
Zidovudine and stavudine inhibit primary human hepatocyte autophagy
In order to validate the effects of NRTIs on hepatocyte autophagy, we cultured primary human hepatocyte in the presence or absence of ZDV (6-150 mmol/l) or d4T (3-75 mmol/l) for 24, 48 and 72 h. For western blot analysis of autophagy in a separate set of the above-mentioned conditions the activator of autophagy PP242 (5 mmol/l) was added for the last 2 h with or without ACH for the last 1 h.
Semiquantitative western blot analysis suggested a marginal level of basic autophagic activity in primary human hepatocytes. In order to analyze the potential inhibitory effect of ZDV and d4T on autophagic activity, we stimulated autophagy with the addition of PP242 and then measured the level of autophagic flux as LC3-II band accumulation after the addition of ACH. Control, but not ZDV-treated and d4T-treated cultures, presented a substantial increase in LC3-II band under such stimulating conditions (Fig. 4A ). This effect is suggestive of a suppressed autophagic turnover [28] . ZDV and d4T inhibition of autophagic flux was further confirmed by the ability of the drugs to induce p62 accumulation ( Fig. 4b and c) . Furthermore, the addition of ACH significantly increased p62 accumulation in the control cultures, but not in ZDV-treated and d4T-treated cells, corresponding to an already-inhibited autophagic flux (Fig. 4b and c ) [28] . This inhibition of autophagy was accompanied by mitochondria mass accumulation ( Fig. 4d ) and increased intracellular lipid content (Fig. 4e ). Electron microscopy confirmed an increased number of autophagic compartments containing undegraded lipid droplets, accompanied by abundant presence of mitochondria in ZDV-treated and d4T-treated cultures, as compared to untreated controls ( Fig. 5a  and b ).
Discussion
Microvesicular steatosis, steatohepatitis or liver failure has been reported as a result of prolonged NRTI exposure [1] [2] [3] . Mechanistically, these side effects were explained with drug-induced mitochondrial toxicity [7, 35] . In the recent years substantial progress has been made in our understanding of how NRTI and particularly thymidineanalogues might damage mitochondria [16, 17] . However, little attention has been paid on the elimination of dysfunctional mitochondria, which is a natural mechanism to maintain cellular homeostasis [36] .
In the present study we demonstrated for the first time that ZDV and d4T have the ability to suppress both constitutive as well as induced autophagy in human hepatocytes. We found a strong association between NRTI-mediated inhibition of autophagy and the accumulation of dysfunctional mitochondria with increased ROS production. These results reveal a novel mechanism by which these drugs are able to block a critical cellular mechanism for dysfunctional mitochondria elimination. Furthermore, the ability of ZDV and d4T to inhibit autophagy correlated with their potential to induce intracellular lipid accumulation in hepatocytes.
Autophagy is a major pathway for mitochondrial turnover, which targets dysfunctional mitochondria for degradation [36] , and autophagy inhibition per se has been associated with the accumulation of dysfunctional mitochondria [13] . Our study revealed a close relationship between ZDV and d4T-mediated inhibition of autophagy and the accumulation of dysfunctional mitochondria with increased ROS production. Inability to remove damaged mitochondria might explain their accumulation and the subsequent increase in apoptosis. The involvement of autophagy inhibition in NRTImediated hepatotoxicity in our experimental system as well as its clinical relevance is strongly supported by several observations: first, independent experimental read-out systems such as western blot, fluorescence microscopy and flow cytometry combined with inducers and inhibitors of autophagy lead to consistent results, second, the results were obtained with human cells and at therapeutic drug concentrations, third, the effects of the thymidine analogues could be closely resembled by using pharmacological and genetic inhibitors of this degradation pathway and fourth, no effect of 3TC on autophagic activity could be detected in our systems consistent with the clinical observation of no major hepatic toxicity of the drug in HIV patients. It will be interesting to assess the effects of other HIV drugs and combinations in future studies in order to fully explore these novel effects.
The liver is a key regulator of fat metabolism. Fatty liver represents a situation where abundant lipid droplets are present in the cytoplasm of parenchymal cells [9] . Fatty liver or steatosis is believed to result from hepatic inability to compensate the excessive fatty acids uptake by fatty acid breakdown or triglyceride secretion [9] . It has been demonstrated that autophagy participates in hepatic intracellular lipid metabolism and mediates lipid droplet degradation [14] . We observed an association between ZDV and d4T ability to inhibit autophagy and their potential to induce intracellular lipid accumulation. Interestingly, we were able to reproduce these effects by pharmacological and genetic inhibition of autophagy in our experimental system. Increased hepatic triglyceride content was documented in vivo in association with hepatocyte-specific Atg7 gene deletion in mice, previously [14] . Based on the close relationship between defective autophagy and disturbed hepatic lipid droplet degradation, dysfunctional autophagy was suggested as potential pathogenic mechanism of fatty liver [9, 14] . As ZDVand d4T did not interfere with early autophagosome formation, we speculate that these NRTI interfere with downstream events of autophagic process. This inhibition may help to explain the intracellular lipids accumulation in hepatocytes, given that triglyceride-containing lipid droplets fuse with autophagosome, which then fuse with lysosomes and, thus, deliver triglyceride for lysosomal degradation [14] .
We suppose that NRTI damage mitochondria through previously characterized mitochondrial toxicity [7, 8, 16, 17] and that subsequently dysfunctional mitochondria cannot be eliminated as a result of the here described ability of these drugs to inhibit autophagy. Accumulation of dysfunctional mitochondria in turn results in increased ROS and triggers cellular apoptosis.
Apoptosis in combination with impaired proliferation and intracellular lipid accumulation could contribute to liver degeneration and disease, especially in conditions, in which extra metabolic, infectious (hepatitis C virus) or drug-related toxicity may accumulate. Alternative aggravation may result from other interactions given that an increased hepatic lipid content was found to impair autophagy [14] and, therefore, potentially may close a vicious cycle. Furthermore, the situation might be worsened by the fact that hepatic autophagy seems to be suppressed by insulin resistance and hyperinsulinemia, both of which are characteristic features of metabolic syndrome [37] . These mechanisms may be important for the development of liver pathology and nonalcoholic fatty liver disease in HIV-patients.
Taken together, our study reveals a novel mechanism on how thymidine analogues contribute to liver cell toxicity.
These data provide also evidence for an important role of autophagy in nonalcoholic fatty liver disease in HIV patients.
